Moreover, by interfering with IDO activity, PpIX-NLG@Lipo amplifies PDT-induced immune responses, resulting in an increased infiltration of CD8+ T lymphocytes at the tumor site and ultimately inhibiting both primary and distant tumors (53). This evidence concerns the gene IDO1 and neoplasm.